Sanofi Stock

Sanofi EBITDA per Employee

The EBITDA per Employee of Sanofi (SAN.PA) as of Aug 17, 2026 is 114,402.69 EUR. In the previous year, EBITDA per Employee was 107,703.30 EUR — a change of 6.22% (higher).

EBITDA per Employee

114,402.69EUR

YoY

6.22%

Last updated:

EBITDA per Employee of Sanofi is 2026 114,402.69 EUR. EBITDA per Employee of Sanofi was 2025 107,703.30 EUR. It decreases by 6.22% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

EBITDA per Employee of Sanofi is 114,402.69 EUR in 2026.

EBITDA per Employee of Sanofi changed from 107,703.30 EUR to 114,402.69 EUR, representing a 6.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Sanofi since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Sanofi historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Sanofi

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Sanofi